Cancer Immunotherapy Program

About Cancer Immunotherapy

The Cancer Immunotherapy Program brings together basic scientists, translational investigators and clinician scientists to discover fundamental principles that regulate immune responses to cancer and to translate this understanding into novel cancer therapies. A major focus is on comprehensive immune profiling, using tools for high dimensional analysis of immune responses. Fundamental modeling of cancer therapeutics is conducted in murine models and the Program has an increasing effort in translating novel therapeutics to the clinic and utilizing patient samples to study the tumor:immune interface.

Program Aims: 

  • Discover principles regarding the biological basis of immune responses in the context of cancer
  • Develop and use high dimensional and cutting edge technologies and animal modeling to probe immune function and cancer/immune interactions
  • Translate novel therapies to generate robust and effective antitumor immune responses in patients

Program Directors

Professor of Pathology and of Medicine (Immunology and Rheumatology)
Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and of Medicine

Program Directory


Diversity in all forms enhances Stanford Medicine's core missions — education, research and health care. 

Events/ Seminars

Faculty and guest speakers provide updates and expert perspectives on diverse aspects of cancer research.

Funding Opportunities

Expert tutelage and financial support helps trainees develop the independence, critical skills and sense of inquiry that will allow them to meet the challenges and changes that lie ahead.